Author: Ken Dropiewski

LivaNova to Present at the Jefferies and Goldman Sachs Conferences

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced company executives will present at two upcoming healthcare conferences. Chief Executive Officer Damien McDonald and Chief Financial Officer Thad Huston will participate in the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6 in New […]

Merit Medical Announces Leadership Change and Appointment of Interim CFO

SOUTH JORDAN, Utah, May 31, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that Bernard Birkett has resigned as Chief Financial Officer […]

Hancock Jaffe Laboratories, Inc. Announces Pricing of Initial Public Offering

IRVINE, Calif., May 31, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (“HJLI”), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced the pricing of its initial public offering of 1,500,000 units, each unit consisting of one share […]

Novoheart Becomes Member of International Consortium Advancing Cardiac Safety in Drug Development

VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that it has become a member of the Cardiac Safety Technical Committee of the Health and Environmental Sciences Institute (HESI), an industry-led, international consortium including major pharmaceutical and […]

EuroPCR Establishes Nobles Medical Technologies II As The Potential Leader In The Rapidly Growing PFO Closure Market

PARIS, May 31, 2018 /PRNewswire/ — Nobles Medical Technologies II, Inc. (NMT 2) today announced that following a highly successful showing at EuroPCR of the NobleStitch, the company will accelerate its sales, marketing and proctoring efforts to meet the increased demand in both existing countries and new territories.   The company noted receiving un-paralleled […]

MicroVention® Announces FDA Approval For Neuro Stent Device

ALISO VIEJO, Calif., May 31, 2018 /PRNewswire/ — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. stents are the first and only stents PMA approved for […]

Keystone Heart Ltd Announces First Enrollment in REFLECT Phase II incorporating TriGUARD 3™ Cerebral Embolic Protection device

CAESAREA, Israel and TAMPA, Fla., May 31, 2018 /PRNewswire/ — Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection for patients undergoing cardiac procedures, today announced the launch of Phase II of the REFLECT trial to evaluate the safety and efficacy of the next generation of Keystone Heart […]

JC Medical Announces First-in-Human Treatment with the Unique Transfemoral J-Valve TAVI Device for Aortic Regurgitation

BURLINGAME, Calif.–(BUSINESS WIRE)– JC Medical, Inc. announced the treatment of the first patient with the company’s Transfemoral TAVI device, the J-Valve TF System for aortic regurgitation. The first patient was treated at St. Paul’s Hospital – Vancouver, Canada by John Webb, MD, FACC, FSCAI, Director of Interventional Cardiology. There are currently […]

Teleflex to Present at the 39th Annual Goldman Sachs Global Healthcare Conference

WAYNE, Pa.–(BUSINESS WIRE)–Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual Goldman Sachs Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, California, on Wednesday, June 13, 2018 at 2:40 p.m. (PT). A live audio webcast of the […]

Espero BioPharma to Present at the 2018 BIO International Convention, Wednesday, June 6, 2018

JACKSONVILLE, Fla., May 30, 2018 (GLOBE NEWSWIRE) — Espero BioPharma, Inc., (the “Company”) a biopharmaceutical company focusing on the late-stage development and commercialization of drugs to treat cardiovascular diseases, today announced that Quang Pham, Espero’s Chief Executive Officer, will present at the 2018 BIO International Convention at 2:00 PM ET […]